Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events

Circulation

Volumn 105, Issue 15, 2002, Pages 1776-1779

  Ridker, Paul M ^a   Shih, Jessie ^a   Cook, Thomas J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lipids; Lipoproteins; Myocardial infarction; Prevention

Indexed keywords

HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; STATINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCREENING TEST;

ACUTE DISEASE; AGED; ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; LOVASTATIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0037117646     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000014447.06099.FB     Document Type: Article

References (18)

1. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?
2. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
3. Effect of statin therapy on C-reactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
4. Long-term effects of pravastatin on plasma concentration of C-reactive protein
5. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
6. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
7. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
8. Homocysteine and risk of cardiovascular disease among postmenopausal women
9. Plasma homocysteine levels and mortality in patients with coronary artery disease
10. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes
11. Homocysteine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial
12. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/Tex CAPS
13. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer
14. Relation between baseline and on treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
15. Generalized Additive Models
16. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
17. Homocyst(e)ine, diet, and cardiovascular disease
18. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease